In this regard, HHT has been shown to down-regulate MCL-1 in human acute and chronic myeloid leukemia cells [13, 31], chronic lymphocytic leukemia cells [12], and MM cells [20]. The gene discussed is MCL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.